Stock GENOVIS AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Genovis AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Genovis AB
Mar. 14 Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement CI
Feb. 15 Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Chart calendar Genovis AB

049c17a5614.qnM6TCwd56rmWQBQMohFuewPn7cO9heBNq1KF8UGsaA.70pUFWpW092NEmghV_kB9YJr3dhdx3u3AvIgQ79S2_DPQEh_XHuO4N8TWQ~d4e3931d5657ab5c25f6ee5aa37cc357

Upcoming events on Genovis AB

2024-05-14 Q1 2024 Earnings Release
2024-08-20 02:00 am Q2 2024 Earnings Release
2024-11-08 02:00 am Q3 2024 Earnings Release
2025-02-04 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-07 Q2 2025 Earnings Release (Projected)
2025-11-06 Q3 2025 Earnings Release (Projected)

Past events on Genovis AB

2024-02-14 Q4 2023 Earnings Release
2023-11-14 Q3 2023 Earnings Release
2023-08-23 Q2 2023 Earnings Release
2023-05-15 Q1 2023 Earnings Release
2023-02-14 FY 2022 Earnings Release
2022-11-14 Q3 2022 Earnings Release
2022-08-12 02:00 am Interim 2022 Earnings Release
2022-05-11 Annual General Meeting
2022-04-27 02:00 am Q1 2022 Earnings Release
2022-02-07 FY 2021 Earnings Release
2021-11-12 06:00 am Q3 2021 Earnings Release
2021-08-11 Interim 2021 Earnings Release
2021-04-28 Q1 2021 Earnings Release
2021-02-10 FY 2020 Earnings Release
2020-11-04 Q3 2020 Earnings Release
2020-08-12 Interim 2020 Earnings Release
2020-05-05 09:00 am Annual General Meeting
2020-04-29 02:00 am Q1 2020 Earnings Release
2020-02-04 FY 2019 Earnings Release
2019-12-20 06:30 am Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		60,5
62,0
-2.34%		61,0
58,7
3.97%		93,0
74,7
24.52%		102
106
-3.41%		158
193
-17.97%
155

EBITDA
Million SEK		Released
Forecast
Spread 		13,6
16,0
-15.23%		8,57
6,40
33.95%		30,3
48,1
-36.98%		23,9
29,6
-19.09%		63,9
103
-38.04%
56,4

EBIT
Million SEK		Released
Forecast
Spread 		10,1
12,0
-16.12%		3,14
1,00
214%		24,5
42,3
-41.98%		17,3
22,8
-24.22%		55,8
93,3
-40.16%
44,2

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		9,67
11,0
-12.12%		2,15
0,20
974.5%		24,6
42,4
-41.97%		8,00
22,8
-64.93%		54,9
84,5
-35.09%
44,0

Net income
Million SEK		Released
Forecast
Spread 		9,55
11,0
-13.17%		6,45
0,20
3123%		24,8
42,2
-41.29%		11,2
26,5
-57.78%		61,5
87,1
-29.39%
37,5

EPS
SEK		Released
Forecast
Spread 		0,15
0,20
-25%		0,10
0,00
- 		0,41
0,65
-36.92%		0,19
0,43
-55.6%		0,94
1,34
-29.68%
0,57

Announcement Date05/02/2011/02/2108/02/2215/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million SEK		Released
Forecast
Spread 		42,1
23,7
77.47%		32,6
0,00
- 		21,1
23,8
-11.19%		23,0
25,6
-10.24%		25,7
28,3
-9.04%		71,3
71,6
-0.45%		29,5
44,4
-33.64%		30,2
30,5
-0.87%		27,3
32,6
-16.24%
37,4


33,7


36,5


46,8

EBITDA
Million SEK		Released
Forecast
Spread 		23,4
43,0
-45.67%		11,7
0,00
- 		2,11
5,00
-57.82%		7,00
5,55
26.07%		3,09
6,85
-54.96%		45,1
38,8
16.21%		7,69
19,9
-61.27%		8,19
5,75
42.49%		3,62
7,10
-49.08%
14,2


9,83


11,9


20,6

EBIT
Million SEK		Released
Forecast
Spread 		21,9
40,0
-45.26%		10,1
0,00
- 		0,22
3,25
-93.2%		4,99
4,05
23.28%		1,96
5,35
-63.42%		43,4
37,8
14.81%		5,98
18,4
-67.41%		5,66
4,23
33.75%		0,76
4,50
-83.11%
11,6


7,30


8,66


17,3

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		21,8
38,3
-42.99%


0,21
7,50
-97.19%		5,01
4,05
23.65%		-7,27
5,80
-225.41%		43,7
37,5
16.63%		6,62
5,50
20.31%		4,27
5,60
-23.77%		0,23
3,60
-93.72%
13,1


5,10


5,80


6,00

Net income
Million SEK		Released
Forecast
Spread 		22,2
40,0
-44.48%		12,3
0,00
- 		0,67
2,10
-68%		5,71
2,90
96.83%		-7,51
5,80
-229.45%		43,6
37,5
16.17%		15,2
5,30
187.15%		3,14
4,70
-33.23%		-0,42
4,05
-110.42%
8,80


5,55


6,05


3,29

EPS
SEK		Released
Forecast
Spread 		0,35
16,7
-97.91%


0,01
-0,01
200%		0,09
0,00
- 		-0,11
0,09
-222.22%		0,67
0,60
11.67%		0,23
0,08
187.5%		0,05
0,10
-50%		-0,01
0,32
-103.17%
0,14


0,78


0,92


0,31

Announcement Date08/02/2227/04/2212/08/2215/11/2215/02/2316/05/2324/08/2315/11/2315/02/24----

Upcoming sector events for Genovis AB

2024-05-01 MYRIAD GENETICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-02 07:00 am LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release
2024-05-02 04:05 pm CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release
2024-05-09 DIASORIN S.P.A.: Q1 2024 Earnings Release
2024-05-12 SD BIOSENSOR, INC: Q1 2024 Earnings Release (Projected)
2024-07-17 02:00 am VITROLIFE AB: Q2 2024 Earnings Release
2024-07-29 AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected)
2024-07-31 MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-31 10X GENOMICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Genovis AB

Today 04:05 pm 10X GENOMICS, INC.: Q1 2024 Earnings Release
Today ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release
Today SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release
Today SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release
Today ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today CHEMCLIN DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release
Today ASSURE TECH (HANGZHOU) CO., LTD.: Q4 2023 Earnings Release
2024-04-28 WUHAN EASY DIAGNOSIS BIOMEDICINE CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 ANDON HEALTH CO., LTD.: Q4 2023 Earnings Release
2024-04-27 BEIJING STRONG BIOTECHNOLOGIES,INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GENO Stock
  4. Stock
  5. Calendar Genovis AB